The profile is currenly unclaimed by the seller. All information is provided by CB Insights.

iprescribe.net

Stage

Acquired | Acquired

About iPrescribe.net

iPrescribe.net is a mobile e-prescribing application for iOS and Android devices.

iPrescribe.net Headquarter Location

United States

800-513-6821

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing iPrescribe.net

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

iPrescribe.net is included in 1 Expert Collection, including Digital Health.

D

Digital Health

13,075 items

Technologies, platforms, and systems that engage consumers for lifestyle, wellness, or health-related purposes; capture, store, or transmit health data; and/or support life science and clinical operations. (DiME, DTA, HealthXL, & NODE.Health)

Latest iPrescribe.net News

DrFirst acquires the assets of iPrescribe.net

Jan 12, 2016

Elettromeccanica S.r.l. 's Assets DrFirst , a leading provider of electronic prescribing and secure texting solutions for healthcare providers, announced today it has acquired the assets of iPrescribe.net , a mobile e-prescribing application for iOS and Android devices. The move follows a banner year of investment and growth at DrFirst, which raised $42M in financing in 2015 , including $25 million in equity financing from Goldman Sachs. “We are pleased to launch the new year with this exciting acquisition ,” said G. Cameron Deemer, president of DrFirst. “As we head into 2016, we are committed to further expanding our footprint in key areas of our operations, including e-prescribing, medication management and care collaboration, particularly on mobile platforms. Our strong financial footing enables us to seize new opportunities that align with that mission, both domestically and abroad.” DrFirst leads the electronic prescribing market with Rcopia® and EPCS GoldSM, legend drug and controlled substance e-prescribing technologies, already in use by 330 electronic medical record systems, 1,000 hospitals and 20,000 medical practices nationwide. About DrFirst Named one of the fastest growing companies in North America, DrFirst ( www.drfirst.com ) pioneers electronic prescribing, medication management and secure care collaboration solutions that enhance the doctor-patient point of encounter, optimize provider access to patient information, inform the doctor’s clinical view of the patient and improve care delivery and clinical outcomes. Our growth is driven by a commitment to innovation, security and reliability across a wide array of services. We are proud of our track record of service to more than 330 EMR/EHR/HIS partners and an extensive network of providers, pharmacies, hospitals and post-acute care facilities. Connect with us on Twitter  @DrFirst , or on LinkedIn at  www.linkedin.com/company/DrFirst . View source version on businesswire.com: http://www.businesswire.com/news/home/20160112005803/en/ DrFirst

  • What is iPrescribe.net's latest funding round?

    iPrescribe.net's latest funding round is Acquired.

  • Who are the investors of iPrescribe.net?

    Investors of iPrescribe.net include DrFirst.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.